RNA, 7SL, cytoplasmic 250, pseudogene (RN7SL250P)

RNA, 7SL, cytoplasmic 250, pseudogene (RN7SL250P) is a non-coding RNA pseudogene related to the 7SL RNA gene. RN7SL pseudogenes—of which RN7SL250P is one—are truncated genomic copies that arose by reverse transcription of the functional 7SL RNA, an essential component of the signal recognition particle (SRP) ribonucleoprotein complex. Unlike the canonical 7SL RNA, which mediates the co-translational targeting of secretory proteins to the endoplasmic reticulum, the pseudogene forms do not produce functional RNA and are generally considered transcriptionally inactive. These pseudogenes are not considered therapeutic targets, as they do not code for proteins, have no known biological function, are not directly implicated in disease, and have no drug interactions[1][4][5][8]. Key details: - The majority of 7SL-like sequences in the human genome are pseudogenes; only a few encode functional 7SL RNA, while the rest, including RN7SL250P, are truncated and non-functional[8][5]. - 7SL RNA is related to Alu elements, but the pseudogene variants do not participate in SRP function or signaling[6]. - There is no evidence linking RN7SL250P to disease or use as a biomarker, therapeutic target, or safety concern[1][4]. - The presence of RN7SL pseudogenes is attributed to retrotranspositional activity in evolution, with no assigned biological activity in adults[8][5]. - The entry is **not a true therapeutic target** and, as a pseudogene, features only in genomic annotation, not pharmacological intervention or disease biology[1][4]. Thus, **RN7SL250P is a non-functional RNA pseudogene, not a therapeutic target, with no clinical or pharmacological relevance**.

Other names

RN7SL250P7SL RNA pseudogeneRNA, 7SL, cytoplasmic 250 (pseudogene)